TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Funding News - Reducing Disparities in Epilepsy Treatment

Archive folder iconHistorical Data

  • The information on this page is for historical and research purposes only.
  • For the most current NINDS funding announcements, please see the NINDS list of Active Funding Initiatives or Follow Us on Twitter for the latest funding news.

The National Institute of Neurological Disorders and Stroke (NINDS) encourages grant applications for research on reducing disparities in epilepsy treatment among minority populations.*

Increasingly, health care providers, scientists, and policy-makers view improved access to health care as central to the elimination of health disparities. Therefore, to reduce or eliminate disparities associated with epilepsy, studies are needed to address health care access and delivery issues that affect epilepsy treatment among minorities.

Areas of potential research interest include: patient-based barriers to access, including barriers that are structural (e.g., transportation, availability of care, and the organization of the health care system), financial (e.g., insurance coverage), or personal/family (e.g., living situation, living environment, cultural attitudes and beliefs, and language); provider-based mediators of care (e.g., cultural competency, communication skills, medical knowledge and skills, and biases and stereotyping); factors influencing patient adherence to recommended treatment (e.g., involvement in care, preferences and expectations about treatment, and literacy); factors influencing patient response to therapies (e.g., genetic mutations and biomarkers) that may affect use; and interaction of patient, family, and provider perceptions of epilepsy regarding treatment.

For more information, potential applicants should contact Margaret Jacobs, Program Director, Channels, Synapses, and Circuits Cluster, NINDS, Neuroscience Center, 6001 Executive Boulevard, Room 2113, Bethesda, MD 20892; telephone: 301-496-1917; fax: 301-480-2424; e-mail:, or Dr. Ronnie D. Horner, Program Director, Office of Minority Health and Research, NINDS, Neuroscience Center, 6001 Executive Boulevard, Room 2153, Bethesda, MD 20892; telephone: 301-496-2581; fax: 301-594-5929; e-mail:

*For a more detailed description of this program announcement, please visit the NIH web site at: